Literature DB >> 24198423

Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier.

Chun-Jung Chen1, Yen-Chuan Ou, Jian-Ri Li, Cheng-Yi Chang, Hung-Chuan Pan, Ching-Yi Lai, Su-Lan Liao, Shue-Ling Raung, Chen-Jung Chang.   

Abstract

Though the compromised blood-brain barrier (BBB) is a pathological hallmark of Japanese encephalitis-associated neurological sequelae, the underlying mechanisms and the specific cell types involved are not understood. BBB characteristics are induced and maintained by cross talk between brain microvascular endothelial cells and neighboring elements of the neurovascular unit. In this study, we show a potential mechanism of disruption of endothelial barrier integrity during the course of Japanese encephalitis virus (JEV) infection through the activation of neighboring pericytes. We found that cultured brain pericytes were susceptible to JEV infection but were without signs of remarkable cytotoxicity. JEV-infected pericytes were found to release biologically active molecules which activated ubiquitin proteasome, degraded zonula occludens-1 (ZO-1), and disrupted endothelial barrier integrity in cultured brain microvascular endothelial cells. Infection of pericytes with JEV was found to elicit elevated production of interleukin-6 (IL-6), which contributed to the aforementioned endothelial changes. We further demonstrated that ubiquitin-protein ligase E3 component n-recognin-1 (Ubr 1) was a key upstream regulator which caused proteasomal degradation of ZO-1 downstream of IL-6 signaling. During JEV central nervous system trafficking, endothelial cells rather than pericytes are directly exposed to cell-free viruses in the peripheral bloodstream. Therefore, the results of this study suggest that subsequent to primary infection of endothelial cells, JEV infection of pericytes might contribute to the initiation and/or augmentation of Japanese encephalitis-associated BBB breakdown in concerted action with other unidentified barrier disrupting factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24198423      PMCID: PMC3911661          DOI: 10.1128/JVI.02738-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis.

Authors:  Ayan Ghoshal; Sulagna Das; Soumya Ghosh; Manoj Kumar Mishra; Vivek Sharma; Preeti Koli; Ellora Sen; Anirban Basu
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

2.  Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.

Authors:  Frederik Eisele; Dieter H Wolf
Journal:  FEBS Lett       Date:  2008-11-27       Impact factor: 4.124

3.  Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia.

Authors:  Ya-Yu Wang; Chun-Jung Chen; Shih-Yi Lin; Yu-Han Chuang; Wayne Huey-Herng Sheu; Kwong-Chung Tung
Journal:  Mol Cell Endocrinol       Date:  2012-12-29       Impact factor: 4.102

4.  Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.

Authors:  Hui Xie; Yi-Xue Xue; Li-Bo Liu; Yun-Hui Liu
Journal:  Brain Res       Date:  2010-01-18       Impact factor: 3.252

5.  Endothelial Japanese encephalitis virus infection enhances migration and adhesion of leukocytes to brain microvascular endothelia via MEK-dependent expression of ICAM1 and the CINC and RANTES chemokines.

Authors:  Ching-Yi Lai; Yen-Chuan Ou; Cheng-Yi Chang; Hung-Chuan Pan; Chen-Jung Chang; Su-Lan Liao; Hong-Lin Su; Chun-Jung Chen
Journal:  J Neurochem       Date:  2012-08-23       Impact factor: 5.372

6.  Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent.

Authors:  Manoj Kumar Mishra; Kallol Dutta; Shaik Khaleelulla Saheb; Anirban Basu
Journal:  Neurochem Int       Date:  2009-07-21       Impact factor: 3.921

7.  Kinetics of cytokine profile during intraperitoneal inoculation of Japanese encephalitis virus in BALB/c mice model.

Authors:  Vandana Saxena; Asha Mathur; Narendra Krishnani; Tapan N Dhole
Journal:  Microbes Infect       Date:  2008-07-19       Impact factor: 2.700

8.  A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model.

Authors:  Allison C German; Khin Saw Aye Myint; Nguyen Thi Hoang Mai; Ian Pomeroy; Nguyen Hoan Phu; John Tzartos; Peter Winter; Jennifer Collett; Jeremy Farrar; Alan Barrett; Anja Kipar; Margaret M Esiri; Tom Solomon
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-06-30       Impact factor: 2.184

9.  Transcriptomic profile of host response in Japanese encephalitis virus infection.

Authors:  Nimesh Gupta; P V Lakshmana Rao
Journal:  Virol J       Date:  2011-03-04       Impact factor: 4.099

10.  Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation.

Authors:  Yoko Ozawa; Keiko Nakao; Toshihide Kurihara; Takuya Shimazaki; Shigeto Shimmura; Susumu Ishida; Akihiko Yoshimura; Kazuo Tsubota; Hideyuki Okano
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

View more
  38 in total

1.  A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.

Authors:  Mélissanne de Wispelaere; Marie-Pascale Frenkiel; Philippe Desprès
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  Computational prediction of miRNAs in Nipah virus genome reveals possible interaction with human genes involved in encephalitis.

Authors:  Sandeep Saini; Chander Jyoti Thakur; Varinder Kumar; Suchita Tandon; Varuni Bhardwaj; Sonia Maggar; Stanzin Namgyal; Gurpreet Kaur
Journal:  Mol Biol Res Commun       Date:  2018-09

3.  RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.

Authors:  Fang Chen; Arijit Ghosh; Mei Hu; Yan Long; Hongbin Sun; Lingyi Kong; Hao Hong; Susu Tang
Journal:  Neurotox Res       Date:  2017-09-04       Impact factor: 3.911

4.  Tembusu Virus entering the central nervous system caused nonsuppurative encephalitis without disrupting the blood-brain barrier.

Authors:  Sheng Yang; Yufei Huang; Yonghong Shi; Xuebing Bai; Ping Yang; Qiusheng Chen
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

5.  Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells.

Authors:  Christian Bleau; Aveline Filliol; Michel Samson; Lucie Lamontagne
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

Review 6.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

Review 7.  Pathophysiologic mechanisms of cerebral endotheliopathy and stroke due to Sars-CoV-2.

Authors:  Visesha Kakarla; Naoki Kaneko; May Nour; Kasra Khatibi; Fanny Elahi; David S Liebeskind; Jason D Hinman
Journal:  J Cereb Blood Flow Metab       Date:  2021-02-02       Impact factor: 6.960

Review 8.  Tryps and trips: cell trafficking across the 100-year-old blood-brain barrier.

Authors:  Marina Bentivoglio; Krister Kristensson
Journal:  Trends Neurosci       Date:  2014-04-27       Impact factor: 13.837

9.  In Vitro Infection with Dengue Virus Induces Changes in the Structure and Function of the Mouse Brain Endothelium.

Authors:  Myriam L Velandia-Romero; María-Angélica Calderón-Peláez; Jaime E Castellanos
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

Review 10.  Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier.

Authors:  Jonathan J Miner; Michael S Diamond
Journal:  Curr Opin Immunol       Date:  2015-11-16       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.